Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061966) titled 'Real-world effectiveness of existing therapies in patients with pancreatic cancer in Japan using genomic data' on June 30.
Study Type:
Observational
Primary Sponsor:
Institute - Eli Lilly Japan K.K.
Condition:
Condition - Advanced/metastatic pancreatic ductal adenocarcinoma (PDAC)
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate the effectiveness of existing therapies using objective response rate (ORR) in a C-CAT cohort adjusted to match baseline characteristics of the JZQA trial cohort.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - ...